Blood banking and transfusion medicine challenges during the COVID-19 pandemic

SARS-CoV-2 (also known as COVID-19) has been unprecedented challenge in many parts of the medical field with blood banking being no exception. COVID-19 has had a distinctly negative effect on our blood collection nationwide forcing blood banks, blood centers, and the U.S. government to adopt new policies to adapt to a decreased blood supply as well as to protect our donors from COVID-19. These policies can be seen distinctly in patient blood management and blood bank operations. We are also faced with developing policies and procedures for a nontraditional therapy, convalescent plasma; its efficacy and safety is still not completely elucidated as of yet.

• Tipo de recurso: Article of investigation
• Fecha de publicación: 2020
• Institución: Universidad de Bogotá Jorge Tadeo Lozano
• Repositorio: Expeditio: repositorio UTadeo
• Idioma: eng
• OAI Identifier: oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12570
• Acceso en línea: https://doi.org/10.1016/j.cll.2020.08.013; http://hdl.handle.net/20.500.12010/12570
• Palabra clave: COVID-19; Blood banking; Transfusion medicine; Blood shortage; Blood wastage; FDA donation policies; Convalescent plasma; Síndrome respiratorio agudo grave; COVID-19; SARS-CoV-2; Coronavirus
• License: Acceso restringido